[1] Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries:implications for new vaccines[J].Nat Rev Immunol,2005,5(8):661-667.
[2] 张舒林,王洪海.结核分枝杆菌特异性抗原检测的研究现状及展望[J].中国热带医学,2008,8(2):299.
[3] 阳幼荣,李邦印,吴雪琼,张俊仙,梁艳,李洪敏,王兰,张翠英,孟祥红,朱琰.结核分枝杆菌16kD重组蛋白的纯化及血清学诊断应用价值的研究[J].中国医师杂志,2007,9(6):742.
[4] Tanghe A,Lefèvre P,Denis O,D’Souza S,Braibant M,Lozes E,Singh M,Montgomery D,Content J,Huygen K. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport recep tors[J]. J Immunol, 1999,162(2):1113-1119.
[5] Romano M,Roupie V,Hamard M,Huygen K.Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosis[J]. Vaccine, 2006, 24(21): 4640-4643.
[6] Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins[J]. Infect Immun, 1994,62(6):2536-2544.
[7] Pal PG, Horwitz MA. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis[J]. Infect Immun,1992,60(11):4781-4792.
[8] 苏明权,岳乔红,周萍,段艳,杨柳,杨军兰,刘家云,郝晓柯.结核分枝杆菌重组蛋白的制备及抗原性分析[J].第四军医大学学报,2006,27(11):987-990.
[9] 顾田园,蔡宏,田霞,余大海,朱玉贤.结核分枝杆菌DNA疫苗的免疫原性和保护效率的比较研究[J].高技术通讯,2005,15(2):79-82.
|